Tenaya Therapeutics partners with Alnylam for heart disease targets
Go back to Tenaya Therapeutics partners with Alnylam for heart disease targets| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 246.11 +5.42 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.69 | 52 Week High | $109.10 | |||
| Open | $242.40 | 52 Week Low | $31.38 | |||
| Day High | $248.13 | P/E | N/A | |||
| Day Low | $238.00 | EPS | $-1.45 | |||
| Volume | 1,941,271 | |||||
| (NASDAQ: TNYA) | Delayed: 0.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $ | |||
| Open | $0.69 | 52 Week Low | $ | |||
| Day High | $0.70 | P/E | N/A | |||
| Day Low | $0.68 | EPS | $ | |||
| Volume | 1,080,686 | |||||
